These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Author: Sullivan JR, Hurley TH, Bolton JH.
    Journal: Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418.
    Abstract:
    Repeated single doses of busulfan (50-200 mg) were given over 1--2 days to 17 patients with chronic myeloid leukemia. The mean survival time was 137 weeks. In this small trial the drug was shown to be safe in most but not all patients and as effective as continous busulfan.
    [Abstract] [Full Text] [Related] [New Search]